Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Nadano
S. Nadano
Medicine
Internal medicine
Metastatic hepatocellular carcinoma
Ovarian cancer
In vivo
2
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
501 Immunological STAT3 knockdown associated with anti-tumor activity in pre-clinical models translates to clinical samples, suggesting immune modulation contributes to the clinical activity of AZD9150, a therapeutic STAT3 ASO
2014
European Journal of Cancer
Patricia McCoon
Rich Woessner
Rachel DuPont
Kirsten Bell
Michael Collins
Lourdes Pablo
Deborah Lawson
Prasad Nadella
V Jacobs
Chris Womack
Corinne Reimer
David S. Hong
John Nemunaitis
Y K Kang
T. Y. Kim
H. Y. Lim
T. Okusaka
S. Nadano
C. C. Lin
Paul Lyne
Show All
Source
Cite
Save
Citations (0)
217 Results of a phase I, open-label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumour activity of AZD9150 in patients with advanced/metastatic hepatocellular carcinoma
2014
European Journal of Cancer
Y K Kang
B-Y Ryoo
T. Y. Kim
K H Lee
H. Y. Lim
Samantha J. Lee
Masafumi Ikeda
T. Okusaka
S. Nadano
C. C. Lin
T. P. Poon
C.-J. Yen
Patricia McCoon
F. Neumann
K. Vishwantahan
Rachel DuPont
Paul Lyne
Show All
Source
Cite
Save
Citations (6)
1